Int J Pharm Pharm Sci, Vol 12, Issue 8, 129-135Original Article

IN VITRO ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITIES OF ALCHORNEA CORDIFOLIA (SCHUMACH AND THONN.) MULL. ARG. AND ANTROCARYON KLAINEANUM PIERRE EXTRACTS

ROSETTE CHRISTELLE NDJIB1,2, STEVE VALDI DJOVA3, CHRISTELLE WAYOUE KOM4, AGBOR GABRIEL AGBOR4, AMINA MAMAT4, SIEGFRIED DIDIER DIBONG1, MAXIMILIENNE ASCENSION NYEGUE5*

1Laboratory of Botany and Traditional Medicine, Institute of Medical Research and Study of Medicinal Plants, PO, Box 13033 Yaounde, Cameroon, 2Laboratory of Biology and Physiology of Plant Organisms, Faculty of Science, University of Douala, PO. Box 24157 Douala, Cameroon, 3Department of Biochemistry, University of Yaounde I, PO Box 812 Yaounde, Cameroon, 4Laboratory of Pharmacology, Institute of Medical Research and Study of Medicinal Plants, PO. Box 13033 Yaounde, Cameroon, 5Laboratory of Microbiology, Faculty of Science, University of Yaounde I, PO. Box 812 Yaounde, Cameroon
Email: maxy_nyegue@yahoo.fr

Received: 12 May 2020, Revised and Accepted: 25 Jun 2020

ABSTRACT

Objective: This study aims to evaluate the in vitro antioxidant, anti-inflammatory activities of the aqueous and hydroethanolic extracts recipe of Alchornea cordifolia and Antrocaryon klaineanum. A preliminary phytochemical screening was carried out.

Methods: The total phenols content was determined by the Folin Ciocalteu reagent method, while the antioxidant activity of both extracts was characterized by the 2-2diphenyl-1-picrilhidrazil (DPPH) and β-carotene assays. The anti-inflammatory activity of the extracts was evaluated as the inhibition of Bovine Serum Albumin (BSA) denaturation and antiproteinase activity.

Results: The aqueous extracts of Alchornea cordifolia and Antrocaryon klaineanum contained more polyphenols [270 mg Ascorbic acid equivalent (AAE)/g dry weight (dw)] than the hydroethanolic recipe extract (262.41 mg AAE/g dw) at the same concentration level. On the other hand, the aqueous and hydroethanolic recipe extract had the same radical scavenging activity with the antiradical power of 0.851 and 0.830, respectively. Similarly, the recipe extract had the same reducing activity with reducing the power of 94.2±2.03 mg EAA/g dw and 97.4±4.16 mg EAA/g dw for the aqueous and hydroethanolic recipe extract of Alchornea cordifolia and Antrocaryon klaineanum respectively. For the anti-inflammatory activity it was observed that both extracts possess the same activity as Diclofenac® with an IC50 of 50.21 μg/ml. The phytochemical screening of the extracts revealed the presence of alkaloids, flavonoids, carbohydrates, phenols and tannins, which may account for their activities.

Conclusion: The plant recipe extract studied possess antioxidant and anti-inflammatory potentials, which may be beneficiary to its consumers.

Keywords: Antioxidant, Anti-inflammatory, Alchornea cordifolia, Antrocaryon klaineanum, Phytochemical study, Recipe

© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
DOI: http://dx.doi.org/10.22159/ijpps.2020v12i8.38272. Journal homepage: https://innovareacademics.in/journals/index.php/ijpps.

INTRODUCTION

Free radicals are known as Reactive Oxygen Species (ROS) are produced by the human body in a normal metabolic process and its environ. There is a permanent system of antioxidant defense of the body against ROS but, an imbalance between antioxidants and pro-oxidants in favor of pro-oxidants leads to oxidative stress [1]. Oxidative stress and inflammation are strongly linked [2, 3]. Inflammation, when it reacts disproportionately, it may be inappropriate, pathological and altering homeostasis thus, contributing to the onset of disease [4]. The synthetic anti-inflammatories and antioxidants currently used are associated with serious side effects like weight gain, gastric irritation [5]. Therefore, the development of anti-inflammatory drugs with little or no side effects is needed from medicinal plants. Alchornea cordifolia (Schumach. and Thonn.) Müll. Arg (Euphorbiaceae), also called “aboe” in ewondo, “dibobondji” in Douala, is one of such plants which is widely distributed in tropical and subtropical regions of Africa. In the central and coastal regions of Cameroon, Dibong et al. [6] reported that the leaves of this plant are used for the treatment of anemia. This plant has many order traditional applications, including treatment of pain and inflammatory disorders, hormonal-related gynecological disorders, infertility, urinary, respiratory and intestinal problems as well as malaria-like fevers and anti-HIV1 integrase activity [7-16]. Earlier studies on the chemical constituents of A. cordifolia identified compounds such as tannins, phenolic acids, flavonoids and alkaloids [11]. The varied popular uses of different parts of A. cordifolia have led to many modern pharmacological investigations like antibacterial [16], antifungal [17], spasmolytic [18] and reproductive activities [13]. Antrocaryon klaineanum Pierre (Anacardiaceae) called “angongui” in ewondo, “ngonga” in bassa is an evergreen tree, deciduous, medium-sized up to 35 to 45 m tall [19]. The barks of Antrocaryon klaineanum are used as a decoction for the treatment of painful periods, sales ailments and even sexually transmitted infections in Cameroon [6]. The crude extract and the isolated compounds of this plant were evaluated for their ability to inhibit the 3D7 strain of Plasmodium falciparum and were evaluated to treat liver complaints and to facilitate the production of breast milk [20, 21]. Phytochemical studies of A. klaineanum extracts have shown the presence of secondary metabolites with antimalarial properties [22]. As of now, very few authors reported the evaluation of the antioxidant and anti-inflammatory activities of the recipe from these plant. Therefore, the aim of the present study was to evaluate the antioxidant and anti-inflammatory activities of the aqueous and hydroethanolic extracts recipe of Alchornea cordifolia (Schumach and Thonn.) Müll. Arg. and Antrocaryon klaineanum Pierre.

MATERIALS AND METHODS

Plant extracts

The leaves of Alchornea cordifolia were collected in the locality of Mfou Center Region of Cameroon in July 2017. The plant identification was done at the Cameroon National Herbarium by comparison with specimen number 9657/SRF/Cam of Alchornea cordifolia (Schumach and Thonn.) Müll. Arg. (Euphorbiaceae).

The barks of Antrocaryon klaineanum were collected in July 2017, in Ebolowa (Southern Region of Cameroon). The plant identification was done at the Cameroon National Herbarium by comparison with specimen number 1742/SRF/Cam of Antrocaryon klaineanum Pierre (Anacardiaceae).

The fresh vegetal material collected was dried in the shade at room temperature (25 °C) for two weeks to constant weight. The aqueous extracts were prepared by boiling 100 mg of plant material in 1000 ml of water. The hydro-ethanol extract was obtained from a maceration of 100 g of plant material in 1000 ml of water-ethanol (70:30).

The boiled extracts obtained was allowed to cool and then filtered using a 0.23 mm diameter filter. The filtrate is then left on the bench for 24 h and the supernatant dried in a lyophilizer.

The macerate obtained is filtered on hydrophilic cotton and then on Wattman No. 1 paper, then the filtrate is dried in an oven at 70 °C for 48 h. The dried extracts obtained were weighed and stored in the refrigerator at 4 °C.

As indicated in an ethnobotanical study, Alchornea cordifolia and Antrocaryon klaineanum are the most plants used in the treatment of infectious diseases in four cities of Cameroon as reported by Ndjib et al. [23]. For the preparation of the recipe solutions from the obtained plant extracts, the same amount of mass of each extract is weighed and solubilized in sterile distilled water to obtain a final concentration of 100 mg/ml [24].

Determination of the total phenols content by the Folin-Ciocalteu method

The total polyphenols were evaluated according to the spectrophotometric method using the Folin-Ciocalteu reagent as described by Chew et al. [25]. In this method, 1817 μl of distilled water was introduced into the test tube, 115 μl of Folin Ciocalteu diluted 1:10 and 345 μl of 15% sodium carbonate (Na2CO3) were added. Tubes were vortexed and incubated for 2 h, and the absorbance measured at 765 nm. Calibration was performed using a freshly prepared aqueous solution of Ascorbic acid.

DPPH radical scavenging test

The molecule of 1,1-diphenyl-2-picrylhydrazyl (DPPH) is characterized as a stable free radical by virtue of the delocalization of the spare electron over the molecule as a whole, so that the molecule does not dimerize, as would be the case with most other free radicals. To prepare a standard solution of 1,1-diphenyl-2-picrilhidrazil (DPPH°), 10 mg of DPPH was dissolved in 25 ml of methanol [26]. From this solution, 5 ml was taken and mixed with 45 ml of methanol. After preparing the different solutions, 1950 µl of the DPPH solution was pipetted into test tubes and 50 µl of each extract at different concentrations was then added to each test tube to a final volume of 2 ml per tube. All tests were carried out in triplicate in a dark room. The optical density was measured at a wavelength of 515 nm using a spectrophotometer of the brand Jenway 6305, Germany, after 120 min of incubation.

Kinetic study, development of study conditions

At the beginning of this evaluation, a kinetic study of the reactivity of DPPH with the different extracts recipe was carried out. It consisted in monitoring the reactivity of the DPPH over time by measuring the absorbance every 15 min for 120 min [27].

β-carotene bleaching coupled the auto-oxidation of linoleic acid assay

The reductive capacity of extracts was estimated by the method [27] as described previously by Moure et al. [28] and Djova et al. [29].

Anti-inflammatory assays

Bovine serum albumin (BSA) denaturation assay

Protein denaturation was performed as described by Djova et al. [30].

Proteinase inhibitory action

The anti-proteinase activity of ASE was determined using the Oyedepo and Famurewa method [31] with slight modifications. The reaction mixture (2 ml) was containing 0.06 mg trypsin, 1 ml of 20 mmol Tris HCl buffer (pH 7.4) and 1 ml test sample of different concentrations. The reaction mixture was incubated at 37 °C for 5 min and then 1 ml of 5% (W/V) casein was added. The mixture was incubated for an additional 20 min, 2 ml of 70% perchloric acid was added to terminate the reaction. Cloudy suspension was centrifuged and the absorbance of the supernatant was read at 210 nm against buffer as blank. The experiment was performed in triplicate.

Chemical screening

The secondary metabolites present in the plant extracts studied were investigated through several methods that differ in their reagents and solvents as well as in the coloration observed and their presence was noted (+) and their absence (-) [32].

Data analysis

Graphs were obtained using the Microsoft Excel 2013 Spreadsheet. Statistical analyzes were performed in GraphPad/Prism 7 for Windows (San Diego, California, USA) and ANOVA Windows SPSS 23 software. The analysis of the variance (ANOVA) was used to compare the averages between more than two groups. The materiality threshold was set at p<0.05.

RESULTS

Total phenolic content

The evaluation of the total phenolic content in the extracts made it possible to quantify them in two categories of antioxidants as shown in table 1.

Table 1: Total polyphenol content of a mixture of aqueous and hydroethanolic extracts

Extracts Total phenols Primary antioxidants Secondary antioxidants
(mg EAA/g dw) (mg EAA/g dw) (mg EAA/g dw)
(Ac1+Ak1) 270.8±0.1** 8.330.34* 94.2±2.03*
(Ac2+Ak2) 262.41±0.3** 8.490.3* 97.4±4.16*

Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v). Values ​​that have the same symbols are statistically identical (*p ˃0.05). Statiscaly differences between total polyphenols content of combined aqueous and hydroethanolic extracts of Alchornea cordifolia and Antrocaryon klaineanum (**p˂0.001).

In this table, it can be seen that the aqueous extract (270.8±0.1 mg AAE/g dw) composed of extracts of equal proportions of Alchornea cordifolia and Antrocaryon klaneanum, had a higher total phenolic content than the hydroethanolic extract (262.41±0.3 mg AAE/g dw) composed of extracts of same proportion of the same plants. It was also noted that the extracts had a higher amount of preventive antioxidant with the content of 94.2±2.03 mg AAE/g dw and 97.4±4.16 mg AAE/g dw respectively for the combined aqueous extract of Alchornea cordifolia and Antrocaryon klaineanum and combined hydroethanolic extract of Alchornea cordifolia and Antrocaryon klaineanum than that of the curative antioxidant (8.330.34 mg AAE/g dw and 8.490.3 mg AAE/g dw) respectively for the combined aqueous extract of Alchornea cordifolia and Antrocaryon klaineanum and combined hydroethanolic extract of Alchornea cordifolia and Antrocaryon klaineanum.

Kinetics of DPPH scavenging

A kinetic study preceded the antiradical analysis by the DPPH method (fig. 1):

Fig. 1: Absorbance curves of the extracts as a function of time

Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v)

It follows from this curve that the decay of the kinetics curve of the DPPH continues until the 120th min and its stationary state is still not reached.

DPPH antiradical assay

The Ascorbic acid calibration curve for the DPPH test obtained is shown in fig. 2 below:

This curve made it possible to obtain the concentration value for trapping 50% of free radicals (SC50) of Ascorbic acid, which is 0.015±0.000 mg/ml.

The following curve represents the percentage of free radical trapping by the extracts as a function of the concentration (fig.3):

This curve made it possible to obtain the concentrations at which the extracts trap 50% of free radicals (SC50) from which the effective concentrations and the antioxidant power were deduced. The values ​​obtained are recorded in the following table 2.

Fig. 2: Ascorbic acid calibration curve for DPPH

Fig. 3: Curves of the percentages of trapping of free radicals by the extracts, Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v)

Table 2: Anti-free radical efficacy of DPPH by extracts compared to ascorbic acid

Extracts SC50 en mg/ml EC50 PA
Aqueous extract (Ac1+Ak1) 0.47±0.2725* 1.175* 0.851*
Hydroethanolic extract (Ac2+Ak2) 0.048±0.8143 1.2* 0.83*
Ascorbic Acid 0.0150.000 0.375 2.66

Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v). Values ​​that have the same symbols are statistically identical (*p ˃0.05).

The two extracts had substantially the same antiradical activity with statistically identical power of 0.81 and 0.851 respectively for the aqueous and hydroethanolic extracts of Alchornea cordifolia and Antrocaryon klaineanum, but Ascorbic acid with antiradical power of 2.66 had a antiradical activity greater than that of the two extract plants.

β-carotene bleaching assay

The fig. 4 represents the reducing capacity of the aqueous and hydroethanolic extracts by the β-carotene method

This curve made it possible to obtain the IC50 and reducing power values ​​and the values ​​are recorded in the following table 3:

Fig. 4: Curve of the percentages of entrapments as a function of the concentration of the extracts
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v)

Table 3: Reductive capacity of in vitro extracts by the β-carotene test

Extracts µg/ml PR mg EAA/g dw
Aqueous (AC1+Ak1) 2.64±0.11* 94.2±2.03*
Hydroethanolic (Ac2+Ak2) 2.86±0.0655* 97.4±4.16*
Ascorbic Acid 0.53±0.0053

Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanolic extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v). Values ​​that have the same symbols are statistically identical (*p ˃0.05).

Extracts and Ascorbic Acid have statistically different reducing capacities at p = 0.0001 ˂ 0.005. Indeed, the reducing capacity of Ascorbic Acid (0.53±0.0053 μg/ml) is higher than that of the two recipes of aqueous and hydroethanolic extracts (between 2.64±0.11 and 2.86±0.0655 μg/ml) respectively. In addition, the reducing capacity of the recipe composed of same proportions of aqueous extracts of Alchornea cordifolia and Antrocaryon klaineanum (2.64±0.11 μg/ml) is greater than that of the hydroethanolic extracts of the same plants (2.86±0.0655 μg/ml).

Anti-inflammatory assay

The fig. 5 below shows the curve of the percent inhibition as a function of the concentration of the aqueous (Alchornea cordifolia and Antrocaryon klaineanum, v/v) and the hydroethanolic (Alchornea cordifolia and Antrocaryon klaineanum, v/v) extracts compared to the anti-inflammatory reference, Diclofenac®:

The IC50 was determined from the regression line Y = ax+b.

The denaturation test of BSA reveals that the two extracts studied have substantially the same activity as Diclofenac at p<0.05 with an IC50 of 50.21 μg/ml.

The fig. 6 shows percentage inhibition of proteinase extracts and acetylsalicylic acid versus concentration.

This curve made it possible to determine the IC50 and the results recorded in the following table 4:

Fig. 5: Calibration curve of the extracts and Diclofenac and capacity to denature the BSA
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanol extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v)

Fig. 6: Curves showing percentages of proteinase inhibition by extracts
Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanol extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v)

Table 4: Percentage inhibition of proteinase by extracts and acetylsalicylic acid

Echantillons IC50 en µg/ml
Aqueous Extract (Ac1+Ak1) 60±1.52*
Hydroethanolic Extract (Ac2+Ak2) 75±2.08*
Ascorbic Acid 10±0.57

Legend: (Ac1+Ak1): aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v); (Ac2+Ak2) hydroethanol extracts Alchornea cordifolia and Antrocaryon klaineanum (v/v). Values ​​that have the same symbols are statistically identical (*p ˃0.05).

The IC50 values obtained vary from 10±0.57 μg/ml for Acetylsalicylic acid to 60±1.52 μg/ml for the aqueous extract composed in equal proportions of the aqueous extracts Alchornea cordifolia and Antrocaryon klaineanum 75±2.08 for the hydroethanolic acid extract composed in equal proportions of the hydroethanolic extracts of Alchornea cordifolia and Antrocaryon klaineanum. The two extracts have substantially the same activity (p ˃0.05), although different from that of acetylsalicylic acid at the p<0.05 threshold.

Chemical screening

Table 5 below shows the families of bioactive compounds present in the extracts studied:

Table 5: Chemical screening

Plant Extract Alc. Anth. Anthr. Coum. Flav. Gluc. Phe. Sapo. STS Tan.
A. cord. Aq. + + + + + + + + + +
He + + + + + + + + + +
A. klain. Aq. + - - - + + + + + +
He + - - - + + + + + +

Legend: Plant: A. cord: Alchornea cordifolia; A. klain.: Antrocaryon klaineanum; secondary: Secondary metabolites; Anthr.: Anthraquinones; Sapo.: Saponins; STS.: Sterols, Terpenoids and Steroids; Flav.: Flavonoids, Alc.: Alkaloids; Coum.: Coumarines; Phe.: Phenols; Tan.: Tannins; Glucosides. Extract; aq: aqueous; he: hydroethanolic; (+): presence; (-): absence.

Thus, the compound mainly revealed and present in all the extracts are alkaloids, flavonoids, carbohydrates, phenols and tannins.

DISCUSSION

The determination of the amount of total phenols content of the two extracts recipes previously made showed that the aqueous extract (270 mg AAE/g dw) composed extracts of same proportions of Alchornea cordifolia and Antrocaryon klaneanum, contained more total antioxidants than the hydroethanolic extract (262.41 mg AAE/g dw) composed of extracts of same proportions of the two plants. In addition, both extracts had statistically the same amount of primary antioxidants on the one hand at p = 0.74. On the other hand, the aqueous extract (77±1 mg AAE/g dw) was richer than the hydroethanolic extract (9.9±1.595 mg AAE/g dw) as antioxidants secondary to the threshold of significance (p = 0.0008<0.05).

The preponderance of secondary antioxidants compared with the primary of one of the two extracts studied refers to a preventive role in the treatment of diseases caused by oxidative stress and would justify the use of these plants in the preventive treatment of a pathology that can degenerate into cancer. In several authors highlight, the presence in large quantities of secondary antioxidants in the ethanolic extracts of leaves and bark of cameroonian plants reinforce the use of this plant as indicated in ethnobotany for the treatment of breast cancer [33, 29].

A kinetic study was carried out before the actual test and it was noted that for the two extracts studied, the decay continued until the 120th minute, the stationary state was still not reached and as Nyegue demonstrated in his work on the therapeutic potential of essential oils, such kinetics where the plateau is still not reached in the 120th minute is said to be slow [27]. The reactivity time of the extracts with the DPPH is thus progressive and these extracts could act on the long term on the free radicals at the origin of oxidative stress.

Ascorbic acid SC50 was 0.018±0.001 mg/ml and aqueous and hydroethanolic extracts 0.047±0.2725 and 0.048±0.8143 mg/ml, respectively. In the same time, the aqueous extract alone of Alchornea cordifolia reported an EC50 of 0.026 mg/ml [34]; Although the recipe showed the ability to trap free radicals, its antiradical potential is lower than that of the aqueous extract of Alchornea cordifolia, this result reinforces the idea that the combination of plants in traditional medicine has not always the potentiating effect sought for a specific activity.

The reducing power expressed in mg of Ascorbic acid equivalent per g of dry weight of extract was statistically higher in the aqueous extract composed in the same proportions of the aqueous extracts of Alchornea cordifolia and Antrocaryon klaineanum (70.75±0.34), compared to the reducing power of the hydroethanolic extract composed of hydroethanolic extracts of the same plant species (62.67±0.46) at the significance level p<0.05. Both extracts studied demonstrated a good reducing activity of ferric iron. Nevertheless, the extracts and Ascorbic acid have statistically different reducing capacities at p = 0.0001. Indeed, the reducing capacity of Ascorbic Acid (0.53±0.0053 μg/ml) was higher than that of both extracts. Furthermore, the reductive capacity of the aqueous extract (2.64±0.11 μg/ml) composed in same proportions of the aqueous extracts of Alchornea cordifolia and Antrocaryon klaineanum was greater than that of the hydroethanolic extract (2.86±0.0655 μg/ml) composed in 50: 50 proportions of hydroethanolic extracts of Alchornea cordifolia and Antrocaryon klaineanum. An ethnobotanical, phytochemical and pharmacological review of Alchornea cordifolia has also highlighted its antioxidant properties both in vitro and in vivo [35], reinforcing its therapeutic anti-infective potential. Agbor et al. [33] Report that the extracts of this plant have a high antioxidant activity because of their ability to reduce iron and to trap free radicals. These results are in harmony with those found in the literature that phenolic compounds, most especially flavonoids, possess a strong reducing power [36].

The denaturation test of Bovine Serum Albumin (BSA) revealed that the two extracts studied had substantially the same activity as Diclofenac® with an IC50 of 50.21 μg/ml. With respect to the antiproteinase assay, the IC50 values ​​obtained ranged from 10±0.57 μg/ml for acetylsalicylic acid to 60±1.52 μg/ml for the aqueous extract composed of 50:50 proportions of extracts aqueous solution of Alchornea cordifolia and Antrocaryon klaineanum and 75±2.08 for the hydroethanolic extract compound with same proportions of hydroethanolic extracts of the same plants. Both extracts had substantially the same activity, although it was different from that of Acetylsalicylic acid at p<0.05. The methanolic extract of Alchornea cordifolia has, in the past, demonstrated anti-inflammatory activity [34].

Inflammation is the main producer of reactive forms of oxygen, so it may be interesting to combine anti-inflammatory treatment with antioxidant treatment [37]. Vitamin A, like β-carotene, is a lipophilic antioxidant whose role is to protect the body against reactive forms of oxygen, and many studies tend to demonstrate their involvement in the regulation of inflammation genes [38]. In humans, the addition of antioxidants seems, to a certain extent, to have preventive or beneficial effects on the evolution of several pathologies [39]. Few studies report the effect of antioxidants in equine medicine; however, it appears that antioxidants can be used beneficially in inflammatory conditions [40]. In addition, as part of the prevention of degenerative diseases of the nervous system in horses, it seems that vitamin A such as β-carotene are unavoidable elements.

The chemical screening carried out on the 5 types of plant extracts gave an insight into the different groups of metabolites found there. Indeed, the compounds present in the aqueous extracts were alkaloids, flavonoids, carbohydrates, phenols and tannins. The extracts of Alchornea cordifolia are those containing all ten groups of secondary metabolites sought. This result is the same as those obtained by a large number of studies where Alchornea cordifolia, thanks to its wide range of active ingredients, would be used as a panacea in several African countries and for the treatment of diseases of different orders [41, 35]. In contrast to this study, saponins and alkaloids are absent in the aqueous extract of Alchornea cordifolia [34].

Several factors have been updated to justify the difference in the chemical composition of extracts from several individuals of the same species; the most incriminated being the place and the period of harvest, the treatment suffered by the harvested organ, the mode of drying, the nature of the solvents and many others. Chemical groups such as flavonoids, polyphenols have been the subject of previous studies and the antioxidant and anti-inflammatory properties have been recognized; this would justify the use of these plants in the treatment of infectious and degenerative diseases [29].

CONCLUSION

Alchornea cordifolia and Antrocaryon klaineanum are two cameroonian plants whose virtues have been studied for each one of them. These plants whose active compounds are quite diversified are used in traditional medicine in the treatment of recurrent tropical diseases. In this study, they were associated with the same concentrations and their estimated antioxidant and anti-inflammatory potential. Thus, prepared in two ways, the extracts of the same plant revealed the presence of the same bioactive compounds. The antioxidant potential evaluated was found to be important, although lower than that of the standard molecule. Regarding the anti-inflammatory potential of the extracts studied, it was identical to that of Diclofenac® thus enhancing their use in the management of inflammatory diseases. The anti-inflammatory activity of these extracts, which is substantially the same as that of Diclofenac® supplemented with their antioxidant potential, would be of therapeutic importance for the management of diseases related to oxidative stress.

ACKNOWLEDGMENT

Authors are very grateful to Cameroon National Herbarium (Yaoundé) for the identification of the plant and to Dr. Mokale Aristide for his technical assistance and advice.

FUNDING

Nil

AUTHORS CONTRIBUTIONS

Ndjib Rosette Christelle, Djova Steve Valdi, Kom Wayoué Christelle and Amina Mamat carried out the experiments. Dibong Siegfried Didier and Agbor Gabriel Agbor designed the study. Nyegue Maximilienne Ascension supervised the work and provided the facilities for the study. All authors read and approved the final manuscript.

CONFLICTS OF INTERESTS

The authors declare that there are no conflicts of interest regarding this paper.

REFERENCES

  1. Sruthi D, Zachariah JT. In vitro antioxidant activity and cytotoxicity of black pepper (Piper nigrum L.) and piper species. Int Food Res J 2017;24:75-85.

  2. Nourshargh S, Hordijk PL, Sixt M. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat Rev Mol Cell Biol 2010;11:366-78.

  3. McDonald B, Kubes P. Leukocyte trafficking. Inflammatory diseases of blood vessels. Department of physiology and pharmacology, faculty of medicine, university of calgary, Canada; 2012. p. 28.

  4. Sosa S, Balick MJ, Arvigo R, Esposito RG, Pizza C, Altinier G, Tubaro A. Screening of the topical anti-inflammatory activity of some central american plants. J Ethnopharmacol 2002;81:211-5.

  5. Reddy JS, Rao GD, Lakshmi GR. A review on the anti-arthritic of some medicinal plants. J Glo Tred Pharma Sci 2014;5:2061-73.

  6. Dibong SD, Mvogo Ottou PB, Vandi D, Ndjib RC, Monkam Tchamaha F, Mpondo Mpondo E. Ethnobotany of anti hemorrhoidal medicinal plants in the markets and villages of the center and the coast. Cam J Appl Biosci 2015;96:9072-93.

  7. Noumi E, Yomi A. Medicinal plants used for intestinal diseases in mbalmayo region, central province. Cameroon Fit 2001;72:246–54.

  8. Banzouzi JT, Prado R, Menan H, Valentin A, Roumestan C, Mallie M, et al. In vitro antiplasmodial activity of extracts of Alchornea cordifolia and identification of an active constituent: ellagic acid. J Ethnopharmacol 2002;81:399–401.

  9. Osadebe PO, Okoye FBC. Anti-inflammatory effects of crude methanolic extract and fractions of Alchornea cordifolia leaves. J Ethnopharmacol 2003;89:19–4.

  10. Nia R, Paper DH, Franz G, Essien EE. Anti-angiogenic, anti-inflammatory and anti-oxidant potential of an African recipe: Alchornea cordifolia seeds. Acta Hortic 2005;678:91–6.

  11. Mavar Manga H, Brkic D, Marie DE, Quetin Leclercq J. In vivo anti-inflammatory activity of Alchornea cordifolia (Schumach and Thonn.) Mull. Arg. (Euphorbiaceae). J Ethnopharmacol 2004;92:209–14.

  12. Ajibesin KK, Ekpo BA, Bala DN, Essien EE, Adesanya SA. Ethnobotanical survey of akwa Ibom State of Nigeria. J Ethnopharmacol 2015;3:115-20.

  13. Ajibade TO, Olayemi FO. Reproductive and toxic effects of methanol extract of Alchornea cordifolia leaf in male rats. Andrologia 2015;47:1034–40.

  14. Chinsembu KC. Plants as antimalarial agents in sub-saharan Africa. Acta Trop 2015;152:32–8.

  15. Siwe Noundou X, Krause RW, Van Vuuren SF, Ntinteh DT, Olivier DK. Antibacterial seffects of Alchornea cordfolia (Schumach. and Thonn.) Müll. Arg. extracts and compounds on gastrointestinal, skin, respiratory and urinary tract pathogens. J Ethnopharmacol 2016;179:76–2.

  16. Siwe Noundou X, Thommas M, Musyoka, Vuyani M, Derek T, Ndinteh, et al. Anti-HIV-1 integrase potency of methylgallate from Alchornea cordifolia using in vitro and in silico approaches. Sci Rep 2019;9:47-8.

  17. Agbor GA, Talla L, Ngongang JY. The antidiarrhoeal activity of Alchornea cordifolia leaf extract. Phytother Res 2004;18:873-6.

  18. Tona L, Kambu K, Ngimbi N, Mesia K, Penge O, Lusakibanza M, et al. Antiamoebic and spasmolytic activities of extracts from some antidiarrhoeal traditional preparations used in Kinshasa Congo. Phytomedicine 2000;7:31–8.

  19. Wang BC, Sork VL, Leong M, Smith BT. Hunting of mammals reduces 165 seed removal and dispersal of the afrotropical tree Antrocaryon klaineanum (Anacardiaceae). Biotropica 2007;39:340-7. 

  20. Douanla PD, Kuiate Tabopda T, Tchinda AT, Ewa Cieckiewicz C, Fekam Boyom MFF, Tsabang N, et al. Antrocarines A–F, antiplasmodial ergostane steroids from the stem bark of Antrocaryon klaineanum. Phytochem Rev 2015;117:521–6.

  21. Kemeuze VA, Nkongmeneck BA. Antrocaryon klaineanum pierre. In: Lemmens RHMJ, Louppe D, Oteng Amoako AA. (Eds.) Prota 7: Timbers/Bois d’œuvre 2. [CD-Rom]. PROTA, Wageningen: Netherlands; 2011. p. 85–8.

  22. Tchinda AT, Ngono ARN, Tamze V, Jonville MC, Cao M, Angenot L, et al. Antiplasmodial alkaloids from the stem bark of Strychnos malacoclados. Planta Med 2012;78:377–82.

  23. Ndjib R, Dibong S, Mvogo P, Nyegue MA, Eto B. Ethnobotanical study of medicinal plants used in the treatment og vaginal infections in four towns in Cameroon. Haya: Saudi J Life Sci 2017;2:366-73.

  24. Salau AK, Yakubu MT, Oladiji AT. Antioxidant activity of aqueous extracts of A. leiocarpus and T. avicennioides. Cam J Biol Biochem Sci 2015;23:9-16.

  25. Chew YL, Goh JK, Lim YY. In vitro from the leguminosae family in penisular Malaysia. Food Chem 2009;116:13-8.

  26. Brand Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate. J Food Sci Technol 1995;28:25-30.

  27. Nyegue MA. Chemical and biological properties of essential oils from some aromatic and or medicinal plants in cameroon: evaluation of their anti-radical, anti-inflammatory and antimicrobial activities. Doctoral thesis of the University of Montpellier II and the University of Yaounde I; 2006. p. 194.

  28. Moure A, Cruz JM, Daniel F, Dominguez M, Sineiro J, Dominguez H, et al. Natural antioxidants from residual sources. Fd Chem 2001;72:145-71.

  29. Djova SV, Nyegue MA, Afagnigni AD, Etoa FX. In vitro antioxidant activity, cytotoxicity and genotoxicity of extracts from the leaves and barks of Anthocleista schweinfurthii Gilg (Loganiaceae). Asian J Res Biol Pharm Sci 2018;6:58-9.

  30. Djova SV, Nyegue MA, Messi AN, Afagnigni AD, Etoa FX. Phytochemical study of aqueous extract of Ochna schweinfurthiana F. hoffm powder bark and evaluation of their anti-inflammatory, cytotoxic, and genotoxic properties. Evid Based Complement Altern Med 2019. Doi:org/10.1155/2019/8908343;8.

  31. Oyedepo OO, Famurewa AJ. Antiprotease and membrane stabilizing activities of extracts of fagara zanthoxyloides, olax subscorpioides and tetrapleura tetraptera. Int J Pharmacol 1995;33:65-9.

  32. Harborne JB. Phytochimical method, a guide to modern technique of plants: Chapman and Hall, London, New York; 1998. p. 10017, USA.

  33. Agbor GA, Kuate D, Oben JE. Medicinal plants can be good source of antioxidants: case study in Cameroon. Pak J Biol Sci 2007;10:537-44.

  34. Nga EN, Yinyang J, Baran a Bidias E, Etame Loe G, Dibong SD. Phytochemical and pharmacological study of Alchornea cordifolia (Schum. and Thonn.) Mull. Arg. and Mangifera indica in the traditional treatment of hemorrhoidal disease. J Appl Biosci 2017;109:106-19.

  35. Boniface PK, Ferreira SB, Kaiser CR. Recent trends in phytochemistry, ethnobotany and pharmacological significance of Alchornea cordifolia (Schumach. and Thonn.) Muell. Arg J Ethnopharmacol 2016;191:216-44.

  36. Crozier A, Clifford MN, Ashihara H. Plant secondary metabolites: occurrence, structure and role in the human diet; 2006;26:1001-13.

  37. Moffarts DE, Kirschvink N, Pincemail J, Lekeux P. Impact physiologique et pathologique du stress oxydant chez le cheval. Ann Med Vet 2005;149:1-9.

  38. Azzi A, Gysin R, Kempna P, Munteanu A, Villacorta L, Visarius T, et al. Regulation of gene expression by alpha-tocopherol. Biol Chem 2004;385:585-91.

  39. Sen CK, Packer L. Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr 2000;72:653S-69S.

  40. Kirschvink N, Fievez L, Bougnet V, Art T, Degand G, Smith N, et al. Effect of nutritional antioxidant supplementation on systemic and pulmonary antioxidant status, airway inflammation and lung function in heaves affected horses. Equine Vet J 2002;34:705-12.

  41. Djimeli MN, Chegaing Fodouop SP, Njateng GSS, Fokunang C, Tala DS, Kengni F, et al. Antibacterial activities and toxicological study of the aqueous extract from leaves of Alchornea cordifolia (Euphorbiaceae). BMC Complement Altern Med 2017;17:349-59.